October 5, 2010 Renal Biomarker Qualification Submission: A Dialog Between the FDA-EMEA and Predictive Safety Testing Consortium
October 5, 2010 Urinary Clusterin, Cystatin C, [beta]2-Microglobulin and Total Protein as Markers to Detect Drug-Induced Kidney Injury
Critical Path Institute President/CEO Receives Award of Excellence Raymond L. Woosley, MD, PhD, President/CEO of Tucson-based Critical Path Institute (CPI), was recently presented with the prestigi
Global Partners Join Forces to Speed Development of New TB Drug Combinations FDA applauds effort to take years off development of much needed TB treatments
Critical Path Institute Continues to Expand Stephen Joel Coons, PhD, Joins as Director of the newly formed Patient-Reported Outcomes Consortium
C-Path’s Rick Myers appointed to the Arizona Board of Regents Governor Jan Brewer today appointed one new member to the Arizona Board of Regents, Tucson resident Rick Myers.